FDA’s computer system monitoring is again at the center of a legal case, but this time, whistleblowers are asserting that monitoring was used for retaliation rather than to help catch genuinely criminal activity.
The agency’s computer monitoring ability received attention previously in an insider trading case involving an FDA chemist who was relying...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?